Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders. Here’s the Uni of Sydney press release. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

CannaTech

SEPTEMBER 16, 2018

Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. Many healthcare practitioners possess a knowledge gap about cannabis, as their medical school curriculum didn’t include any information on the topic.

Education 66

Education Medicine Clinical Trials Patients 66

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). Le-Short C.,

Patients 98

Patients Education Marijuana Therapy 98

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

Some of the research that has been done is purely observational, and it is difficult to draw any concrete conclusions or produce hard data. Until recently, it was nearly impossible to access the benefits of marijuana without smoking or cooking it before eating to create the combustion needed. Having hand pain? Use a topical.

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Cannabis Law Report

MARCH 19, 2020

They expressed this concern at a public meeting held by FDA in May 2019, explaining that conflicting regulatory requirements create uncertainty that is stifling medical research and hindering consumer access to CBD products. FDA submitted this report last week, as is discussed below.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Cannabis Law Report

JULY 24, 2022

The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 percent annually to $9.8 billion by 2029. [1]

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

MAY 6, 2022

Generally, a CBD product seller is expected (or required by law) to provide customers with access to a “certificate of analysis” or “COA” associated with specific products, which COA confirms the levels of CBD in products and upon which customers can rely. Taking CBD can relieve pain.”. This client alert does not provide legal advice.

THC 52

THC CBD Media Food 52

Cannabis Law Report

FEBRUARY 17, 2020

The Committee will convene telephonically and in-person bimonthly to develop ways and methods to expand patient access and affordability, increase innovation and technology within the cannabis industry, and to make recommendations to the Legislature and the Department of Health’s Office of Medical Marijuana Use (OMMU).

Dispensary 76

Dispensary Patients Agriculture Conditions 76

The Cannigma

JANUARY 13, 2023

Treating migraine pain is one of the instances where inhaled cannabis consumption, such as smoking or vaping , is important for the right effects and speed of delivery. Edibles won’t produce the same experience, but topicals may be able to help, too. Topical cannabis products can also be useful, but research and data is very limited.

Terpenes 132

Terpenes Strains THC Treatment 132

Project CBD

MAY 3, 2023

She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. I don’t know that it’s a direct sleep agent, but when you are having less anxiety and less pain you likely will fall asleep a little bit easier and maybe sleep better.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Veriheal

AUGUST 31, 2021

His device not only provides an accessible option for cannabis users who are moving away from smoking but also opens up the opportunity for unique experiences with cannabis in the same way Starbucks revolutionized how people drink coffee. . Camille Elliott. School: Villanova University. Major/Program: Nursing. Guinevere Dorado.

Research and Development 116

Research and Development Supply Chain Programs Education 116

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Conclusions. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

FEBRUARY 14, 2021

Despite the traumatic brain injury, chronic pain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Years later, when medical cannabis was legalized in Maryland , where he lives, Smith told The Cannigma how he suddenly had access to a whole world of weed he had never encountered with his old dealer.

Wellness and Beauty 145

Wellness and Beauty Data Terpenes Patients 145

Cannabis Law Report

OCTOBER 1, 2021

Mack will present an overview of Virpax and take part in a fireside chat moderated by Noble Capital Markets senior equity research analyst, Gregory Aurand at the Pain Management Virtual Investor Forum on Thursday, October 7, 2021 at 9:00 a.m. Eastern time. www.youtube.com/channelchek. Channelchek (.com)

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

The Cannigma

APRIL 8, 2021

The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. You definitely deserve access to talk to someone like me. CP: I’m going to say yes and it’s hard to tie this together, but there’s actually some really good animal, and a little bit of human data to support this. Music by Desca. MSO: I agree.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

The Cannigma

FEBRUARY 14, 2021

Despite the traumatic brain injury, chronic pain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Years later, when medical cannabis was legalized in Maryland , where he lives, Smith told The Cannigma how he suddenly had access to a whole world of weed he had never encountered with his old dealer.

Wellness and Beauty 73

Wellness and Beauty Data Terpenes Strains 73

The Cannigma

JANUARY 19, 2022

She explains how the state legislature in New York prevented her from accessing the medication she needed, as well as how difficult it was navigating the world of medical cannabis and finding a product that reliably worked for her. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. Music by Desca.

Patients 83

Patients Compliance Compliance Cannabis 83

MedicalJane

DECEMBER 13, 2017

The state recently announced an expansion to its program that is beginning to open the door to improved patient access. These changes included adding chronic pain and PTSD to its list of qualifying medical conditions. Recent Updates to MMJ Program Aim to Improve Patient Access. Patience by all is emphasized at this time.

Programs 49

Programs Patients Chronic Pain Marijuana 49

Cannabis Law Report

OCTOBER 17, 2019

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018.

Law 40

Law Seed-To-Sale Hemp Recreational 40

SpeedWeed

JULY 10, 2021

This legislation provides important updates to our state’s medical marijuana program to ensure that patients have improved access to medication.”. Under the signed legislation, cannabis producers can remediate contaminants, like mold or yeast, to turn it into products that are not to be inhaled or ingested, such as topicals.

Access 52

Access Research and Development Programs Chronic Pain 52

Cannabis Law Report

NOVEMBER 29, 2021

Numerous states in 2021 also enacted legislation expanding medical cannabis access and stimulating greater diversity among licensed marijuana businesses. “As With respect to medical cannabis policies, numerous legislatures took steps in 2021 to expand patients’ access to marijuana products. MEDICAL MARIJUANA ACCESS. California.

Legislation 98

Legislation Patients Retail Access 98

SpeedWeed

JULY 6, 2021

This legislation provides important updates to our state’s medical marijuana program to ensure that patients have improved access to medication.”. Under the signed legislation, cannabis producers can remediate contaminants, like mold or yeast, to turn it into products that are not to be inhaled or ingested, such as topicals.

Research and Development 52

Research and Development Programs Chronic Pain Legislation 52

SpeedWeed

JULY 5, 2021

This legislation provides important updates to our state’s medical marijuana program to ensure that patients have improved access to medication.”. Under the signed legislation, cannabis producers can remediate contaminants, like mold or yeast, to turn it into products that are not to be inhaled or ingested, such as topicals.

Research and Development 52

Research and Development Programs Chronic Pain Legislation 52